MIRTAZAPINE TEVA 30 MG

Country: Israel

Language: English

Source: Ministry of Health

Buy It Now

Active ingredient:

MIRTAZAPINE

Available from:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

ATC code:

N06AX11

Pharmaceutical form:

TABLETS

Composition:

MIRTAZAPINE 30 MG

Administration route:

PER OS

Prescription type:

Required

Manufactured by:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Therapeutic group:

MIRTAZAPINE

Therapeutic area:

MIRTAZAPINE

Therapeutic indications:

Episode of major depression.

Authorization date:

2013-06-30

Patient Information leaflet

                                PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986
The medicine is dispensed with a doctor’s prescription only
MIRTAZAPINE TEVA
® 30 MG
TABLETS
COMPOSITION:
Each tablet contains:
Mirtazapine 30 mg
For information about inactive and allergenic ingredients,
see section 2 - “Important information about some of
the ingredients of the medicine” and section 6 - “Further
Information”.
READ THE LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING
THE MEDICINE. This leaflet contains concise information
about the medicine. If you have further questions, refer to
the doctor or pharmacist.
• This medicine has been prescribed to treat you. Do not
pass it on to others. It may harm them, even if it seems to
you that their medical condition is similar.
• This medicine is not intended for use in children and
adolescents below
18 years of age
.
• It will take 1-2 weeks until Mirtazapine Teva will start to
work. After 2-4 weeks you may start to feel better. If after
2-4 weeks you do not feel better or if you feel worse you
should speak with your doctor. Additional information
appears in section 3 under the heading “When can you
expect to start feeling better”.
Anti-depression and anti-anxiety medicines elevate
the risk of suicidal behavior and thoughts in children,
adolescents and young adults up to age 25.
When starting the treatment with the medicine, patients
of all ages and their relatives should monitor behavioral
changes, such as: worsening depression, suicidal
thoughts, aggression, and the like.
1.
WHAT IS THE MEDICINE INTENDED FOR?
Mirtazapine Teva is used to treat depression.
THERAPEUTIC GROUP: Preparation from the SNRI group.
2.
BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE IF:
• You are sensitive (allergic) to Mirtazapine or to any of
the additional ingredients contained in the medicine
(see section 6 - “Further Information”). If so, you must
talk to your doctor as soon as possible before beginning
to use Mirtazapine Teva.
• You are taking or have rec
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Hebrew 05-03-2019

Search alerts related to this product